Safety Study of HXN5003 in Healthy Adults
Part of Genetic & congenital, Immune system & allergy, Skin clinical trials.
This is an early-stage safety study testing a new experimental drug called HXN5003 in healthy volunteers. Researchers will give increasing doses to see how safe the drug is and how the body handles it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 55 years old
- Your body mass index (BMI, a weight-to-height ratio) must be between 18 and 32
- You must be in generally good health with no active infections, diabetes, cancer, or serious heart/liver/kidney problems
- You cannot be pregnant, planning to become pregnant, or breastfeeding
- You must not have used tobacco, nicotine, or excessive alcohol in the past 3 months
- You cannot have taken other experimental drugs, certain vaccines, or most prescription medications within the past 30 days
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medicine called HRS-8797 in healthy people. It helps researchers understand how the drug works and if it is safe before testing in patients.
This study tests a new drug called BYN-001 in two groups: healthy people and people with moderate to severe eczema (atopic dermatitis). The goal is to see if the drug is safe and how well it works.
This early-stage trial tests a new experimental medicine called REGN20423 in two groups: healthy volunteers and people with atopic dermatitis (a chronic skin condition causing itching and inflammation). The trial aims to assess whether the medicine is safe and well-tolerated.
This study tests a new ointment (HL-300) designed to treat mild-to-moderate atopic dermatitis (a chronic skin condition causing itching and inflammation). You would apply it to affected skin areas to see if it safely reduces symptoms.
This trial tests a new medicine called BBT001, first in healthy people and then in adults with moderate to severe eczema (atopic dermatitis). It aims to see if the drug is safe and how well it works for treating eczema that hasn't improved with topical treatments.
This study tests an injected medicine called XKH001 for adults with moderate to severe eczema that hasn't been helped enough by creams. It aims to see if it can reduce itching and skin symptoms.
Hear when a new Atopic Dermatitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.